Affluent Medical
About:
Affluent Medical is develops innovative new-generation mini-invasive implants to restore essential physiological functions.
Website: https://www.affluentmedical.com/
Top Investors: Kreos Capital, Edwards Lifesciences
Description:
Affluent Medical develops innovative new-generation mini-invasive implants to restore essential physiological functions in these areas: - Kardiozis aims to prevent endoleaks and risks of recurrence of the abdominal aortic aneurysm allowing patients to live more serenely facing an unpredictable risk of breakage; - Kalios and Epygon aim to provide more physiological surgical treatments for the repair or replacement of the mitral valve of the heart. Kalios can treat residual post-operative leakage and recurrent mitral insufficiency without having to reoperate patients. Epygon is today the only developing transcatheter valve to restore natural blood flow and safeguard the left ventricle. - Finally, Artus is the first electronically activatable artificial sphincter to treat stress urinary incontinence in men and women.
20.5M EUR
Paris, Ile-de-France, France
2011-01-01
contact(AT)affluentmedical.com
51-100
2024-07-15
Public
© 2025 bioDAO.ai